[18F]F-FAPI PET/CT is superior to [18F]F-FDG PET/CT for lymph node staging in lung cancer: a pathologically validated study
European Journal of Nuclear Medicine and Molecular Imaging · 2026-07 · 53 (9) · 5208-5218
DOI: 10.1007/s00259-026-07930-2 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 16.05.2026. Verfasst von Jinjin Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, 4365 Kangxin Road, Shanghai, 201321, China. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18, Lung Neoplasms, Membrane Proteins. Die Arbeit nennt 20 Literaturangaben. Gefördert von: Pudong New area science and technology development foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, 4365 Kangxin Road, Shanghai, 201321, China.
- Shanghai Key Laboratory of Radiation Oncology, Shanghai, China.
- Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, China.
- Department of Oncology, Medical College, Fudan University, Shanghai, China.
- Department of Thoracic Surgery, State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, No.270 Dong'an Road, Xuhui district, Shanghai, 200032, China.
- Institute of Thoracic Oncology, Fudan University, Shanghai, China.
Förderung
- Pudong New area science and technology development foundation
Zitieren
APA
Jiang, J., Li, B., Mao, J., Zhang, J., Li, Z., Song, S., Cheng, J., & Chen, H. (2026). [18F]F-FAPI PET/CT is superior to [18F]F-FDG PET/CT for lymph node staging in lung cancer: a pathologically validated study. European Journal of Nuclear Medicine and Molecular Imaging, 53(9), 5208-5218. https://doi.org/10.1007/s00259-026-07930-2
Vancouver
Jiang J, Li B, Mao J, Zhang J, Li Z, Song S, et al. [18F]F-FAPI PET/CT is superior to [18F]F-FDG PET/CT for lymph node staging in lung cancer: a pathologically validated study. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(9):5208-5218. doi:10.1007/s00259-026-07930-2
BibTeX
@article{Jiang2026,
author = {Jiang, Jinjin and Li, Bin and Mao, Jingfang and Zhang, Jiangang and Li, Zili and Song, Shaoli and Cheng, Jingyi and Chen, Haiquan},
title = {[18F]F-FAPI PET/CT is superior to [18F]F-FDG PET/CT for lymph node staging in lung cancer: a pathologically validated study},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {53},
number = {9},
pages = {5208--5218},
doi = {10.1007/s00259-026-07930-2}
}
EUVIMED